National telemedicine and telehealth policy context in England and introduction of digital innovations for detection and treatment of sexually transmitted infections by Eaton, Susan Elizabeth et al.
  
 
 
 
  warwick.ac.uk/lib-publications 
 
 
 
 
 
Original citation: 
Eaton, Susan Elizabeth, Osipenko, Leeza, Petrou, Stavros, Biggerstaff, Deborah and 
Szczepura, Ala. (2017) National telemedicine and telehealth policy context in England and 
introduction of digital innovations for detection and treatment of sexually transmitted 
infections. SM Journal of Clinical Medicine, 3 (1). pp. 1022-1028.  
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/97856    
       
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work of researchers of the 
University of Warwick available open access under the following conditions. 
 
This article is made available under the Creative Commons Attribution 4.0 International 
license (CC BY 4.0) and may be reused according to the conditions of the license.  For more 
details see: http://creativecommons.org/licenses/by/4.0/   
 
A note on versions: 
The version presented in WRAP is the published version, or, version of record, and may be 
cited as it appears here. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
SM Journal of 
Clinical Medicine
Gr   upSM
How to cite this article Eaton S, Osipenko L, Petrou S, Biggerstaff D and Szczepura A. National 
Telemedicine and Telehealth Policy Context in England and Introduction of Digital Innovations for 
Detection and Treatment of Sexually Transmitted Infections. SM J Clin Med. 2017; 3(1): 1022.
OPEN ACCESS
ISSN: 2573-3680
Introduction
Chlamydia (caused by the gram-negative bacterium Chlamydia trachomatis) is one of the most 
common infections reported in the United States [1] and Europe [2]. The highest rate of infection is 
reported in young people aged 15 to 24 years [3]. This Sexually Transmitted Infection (STI) is largely 
asymptomatic and so regular screening is required to detect, treat and identify partners at risk of 
infection. If left untreated, chlamydia can result in serious long term consequences, particularly 
for women. These include pelvic inflammatory disease, ectopic pregnancy and infertility [4]. Such 
complications result in a future economic burden to health services which can easily be avoided 
with cost-effective screening programmes [2]. For these reasons, a National Chlamydia Screening 
Programme was introduced in England for 16-24 year olds in 2003 [5]. However, despite the 
introduction of this national programme, and the fact that the infection is easy to treat with a single 
dose antibiotic, uptake of opportunistic screening for chlamydia remains low [6]. It has recently 
been highlighted that strategies for control and management of chlamydia will need to leverage 
approaches that go beyond conventional service delivery [7].
The internet has created opportunities for accessing services in ways that were previously 
unfeasible [8]. The transition to digital mobile networks in the early 1990s [9] and the introduction 
of third generation (3G) and 4G networks over the last ten years, coupled with a significant growth in 
smartphones since the launch of the iPhone in 2007, has led to an explosion in the growth of mobile 
phone use in health services (mHealth) [10]. This, coupled with the development of smartphone 
‘apps’, has led to millions of apps available and billions of downloads to date [11,12]. Such advances 
have opened up a wide range of options to improve healthcare delivery processes [13]. 
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Abstract
Chlamydia is the most common Sexually Transmitted Infection (STI) among young people aged 16-24 years 
old. The infection is largely asymptomatic and therefore regular screening is required to detect, treat and identify 
those at risk. If left untreated, chlamydia can result in serious long term consequences, particularly for women. 
These include pelvic inflammatory disease, ectopic pregnancy and infertility. Current levels of screening in the 
England cover only a small proportion of the eligible population.
Technological advances offer the opportunity to redesign existing asymptomatic chlamydia screening/
testing and treatment pathways in England, leading to increased testing uptake, higher treatment rates and 
reduced disease transmission. Innovations underway include self-tests networked through mobile phones, 
combined with online clinical care and other non-face-to-face care pathways. Two levels of integration of 
technology into mainstream sexual health services are possible. The most ambitious is a fully remote online 
pathway incorporating a self-test, plus online treatment and partner notification. A less ambitious service would 
consist of postal home sampling kits with a partial remote online pathway for results notification, treatment 
provision and partner notification.
In this article we discuss the current state of adoption of new technologies in the sexual health service 
delivery pathway within the overall context of digital technology use in England, the emergence of a national 
digital health policy, and challenges to the adoption of telemedicine and telehealth technologies. Consideration 
of these aspects should help technology developers, policy makers and service providers to optimize future 
technology adoption and service re-design in STI care or related clinical areas.
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For STI testing scientific advances are also underway to replace 
conventional diagnostic testing methods with the development of 
point-of-care tests which can be performed outside the laboratory 
[14], and the emergence of self-tests which can be performed in 
the home [15]. These scientific advances are occurring alongside 
the development of online treatment pathways either through 
eHealth clinics or smartphone applications [16]. Two levels of future 
integration of these technological advances into mainstream sexual 
health services are possible. The most ambitious would be a fully 
remote online testing and treatment pathway incorporating a self-
test, plus online treatment and partner notification; a less ambitious 
partially remote telemedicine service would be postal home sampling 
kits with a partial online pathway for results notification, treatment 
provision and partner notification [7]. In the United Kingdom (UK), 
introduction of such technological advances might offer a number of 
benefits for the national chlamydia screening programme however, 
these need to be set within the changing national digital health policy 
context.
In this commentary we discuss digital technology use in England, 
the emergence of a national digital health policy, challenges to the 
adoption of telemedicine and telehealth technologies, and the current 
state of adoption of new technologies in the sexual health service 
delivery pathway.
Terminology
Terms such as telemedicine, eHealth and mHealth are sometimes 
used interchangeably, with mHealth becoming more established 
following the new generation of smartphone and tablet technology. 
In this article we focus primarily on mHealth. The World Health 
Organization (WHO), recognizing the absence of a standardized 
definition of mHealth, defined it in 2011 as “Medical and public 
health practice supported by mobile devices, such as mobile 
phones, patient monitoring devices, personal digital assistants and 
other wireless devices” [17]. A more concise definition offered by 
Free and colleagues in 2013 is “the use of mobile computing and 
communication technologies in healthcare and public health” [13]. 
Mobile devices can enable existing technologies to be utilized in a 
different way, e.g. remote monitoring, as well as extending the scope 
of technologies available for use. In general terminology, mHealth can 
be considered a subset of eHealth which in turn can be considered a 
subset of telemedicine, a summary of their key features of and generic 
examples of their use is presented in Table 1.
Digital Technology Use in the United Kingdom
Data from the Office of Communications which regulates the 
communications market in the UK identified that at the end of 2015 
there were 91.5 million active mobile phone subscriptions [18]. UK 
data on the reported use of the internet to find health information 
shows an increase from 18% in 2007 to 51% in 2016 [19]. There are 
a number of published studies which indicate a preference among 
patients and citizens for the use of the internet to source information 
about management of health conditions [20]. A literature review 
published in 2011 by the European Centre for Disease Prevention and 
Control found that use for this purpose was growing rapidly amongst 
patients, carers, and their friends and relatives, with women and those 
more highly educated most likely to search for health information 
online [21]. The quarterly ‘Technology Tracker’ trends survey 
identified that by the second quarter of 2016, among 15-24 year olds:
•	 Internet access across gender and socioeconomic status is 
consistently high, with the lowest access rate in females in the 
lowest socioeconomic group at 96%.
•	 Smartphone	ownership	across	gender	and	socioeconomic	status	
is also high with 94% of males and 95% of females aged 15-24 
owning a smartphone. The lowest rates of ownership within this 
age group are males in the lowest socioeconomic group at 91% 
[22].
Disparities in overall mobile internet usage and smartphone 
ownership present an important consideration in the development 
of mHealth interventions for chlamydia screening. Whilst apps have 
the benefit of being able to utilise features of the phone such as the 
camera (a potential option for the analysis of test results), websites 
optimised for use on a mobile phone are accessible by all operating 
platforms therefore extending the user base [23]. 
Emergence of Digital Health Policy in England
The National Health Service (NHS) has incorporated technological 
advances into national health policy. Much of the early digital health 
policy in the NHS was centered on addressing Information Technology 
(IT) infrastructure and system deficits within hospitals and primary 
care. The NHS Plan was the first major general policy document to 
acknowledge the need for modern IT systems in both community and 
hospital settings [24]. The plan included a vision where self-care and 
self-management would be facilitated through IT enabling patients to 
email or phone clinicians for advice and support, and to receive their 
test results at home. Over the period 2000-2010, the focus remained 
on the integration of systems through the work of the Connecting 
for Health policy in delivering the National Programme for IT. This 
included the development and implementation of systems linking 
both primary and secondary care including the NHS Care Records 
Service, Choose and Book and the Electronic Prescribing Services 
[25-27]. 
In 2011, the publication of ‘Innovation, Health and Wealth’ 
led to a notable policy shift away from a focus on IT systems to the 
adoption of innovations which could impact directly on the provision 
of patient care. The ‘digital by default’ initiative was first introduced 
in this policy document and reinforced the vision in the original NHS 
Plan [24] that “for many people who use electronic media as part of 
their daily lives, the ability to … have a remote consultation using 
telephone or online technology would offer a much more convenient 
way of accessing NHS services”. This could also enable the NHS to 
drive down the level of inappropriate and unnecessary face-to-face 
contacts and therefore costs [28]. 
More recently, this shift was reinforced by the publication of 
‘Digital First’ in 2012 which aimed to “make available the digital 
means (channels, content, services) for the general public to 
manage their healthcare digitally wherever possible and provide the 
mechanisms and support that ensure they can migrate to these digital 
channels as their preferred manner to engage” [29]. Ten high impact 
digital initiatives were cited which incorporated the use of eHealth 
and mHealth solutions, including use of online and telephone triage, 
online/ remote consultation and Short Message Service (SMS) 
reminders which were expected to deliver an estimated £3bn in 
savings for the NHS [29].
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During this period, digital health initiatives also began to be 
incorporated into healthcare contracting arrangements through 
service specifications, enhanced services and commissioning for 
quality and innovation schemes. The NHS five year forward view, 
published by NHS England in 2014, gave a commitment to expanding 
the use of digital technology in the NHS recognizing the role of a 
range of eHealth and mHealth solutions including health apps, online 
General Practitioner (GP) appointments and patients having full 
access to their electronic health record [30]. 
In order to influence the adoption of health apps, in 2013, the 
NHS launched an ‘Apps Library’, incorporating a range of approved 
apps which had been evaluated and endorsed by the NHS [31]. 
Little information was available on the accreditation process, and 
no indication that apps had been assessed for cost-effectiveness. 
The library was widely criticized with significant concerns raised 
regarding data privacy; 89% of apps that sent data to online services 
and 66% of apps that sent personal information were found not to use 
encryption and no apps encrypted information stored on the device 
[32]. The NHS apps library was removed in 2015 in order to enable 
the apps to be reviewed against set criteria, and is still being upgraded 
[31]. 
Challenges to Adoption of ‘Telemedicine’ in England
To date, the adoption of telemedicine (including eHealth and 
mHealth, see Table 1) at a system level within the NHS and other health 
systems has proved to be a challenge. Evidence on their adoption 
within the NHS for the diagnosis, treatment and management of 
long-term medical conditions indicates that widespread adoption 
is minimal. The Department of Health report published in 2014 
acknowledged that, despite commitments given over the previous 
years in national policy, from a patient perspective “the consumer 
experience of care services remains much as it was before the mobile 
phone and the internet became commonplace. For care professionals, 
from social workers to doctors and nurses, the arrival of the digital 
age has often been experienced not as a force for good but rather as an 
intrusive additional burden in an already pressured existence” [33]. 
A 2011 WHO global survey was the first to comprehensively identify 
barriers to adoption of mHealth by health systems internationally. 
Competing priorities within the health system were identified as the 
most significant barriers to the adoption of mHealth (52%), with lack 
of knowledge about how mHealth can be utilised and its contribution 
to health outcomes, lack of policy on mHealth initiatives at a national 
level, and poor data on cost-effectiveness of mHealth interventions 
being the most commonly cited reasons for not pursuing mHealth 
interventions [17].
In England, with the exception of a few major initiatives that 
have been adopted fairly consistently across the NHS, for example 
text message appointment reminders, the adoption of eHealth and 
mHealth has followed a path of small scale, localised, initiatives with 
minimal structured evaluation, this is not dissimilar to that of other 
nations [17]. Sustained adoption has been heavily influenced by 
clinicians with for example, access to the system for booking online 
hospital appointments, reducing when the financial incentive for 
GP practice participation ceased. The Whole System Demonstrator 
(WSD) project was the largest randomised controlled trial ever 
undertaken in England designed to explore the costs and benefits of 
using telehealth and telecare alongside standard care [34]. The trial 
covered patients in three areas with one or more of the following 
long-term conditions – chronic obstructive pulmonary disease, heart 
failure or diabetes. It considered the barriers to participation and 
adoption of telehealth and telecare within the WSD trial [35] and 
the effect on use of hospital care and mortality [36]. The economic 
evaluation identified that telehealth was unlikely to be cost-effective 
in these conditions where it was provided as an addition to standard 
care, instead of a replacement [37]. 
Adoption of New Technologies in Sexual Health 
Service Delivery Pathways
Internet searches for ‘online NHS clinics’ undertaken as part 
of this commentary identified that a high proportion of results in 
the top 100 related to one of three clinical areas: general practice, 
mental health or sexual health. In the first area, since 2013, there are 
increasing examples of the use of e-consultation in general practice 
with an evaluation identifying that 60% of e-consultations were closed 
remotely, 80% that required a call back were also closed remotely, and 
18% of users who had planned to book a face-to-face appointment no 
longer required one [38,39]. In the second area, mental health, online 
clinics have used innovative services such as Big White Wall leading 
the way with online therapy appointments delivered by instant 
message, video or audio services [40]. The final area, sexual health, is 
a service which is experiencing numerous simultaneous technological 
advances. 
For mainstream NHS chlamydia testing and treatment services, 
the most ambitious fully remote online pathway incorporating a 
self-test, plus online treatment and partner notification has not yet 
been realized. There are currently no self-tests available for chlamydia 
which have a suitable accuracy. Similarly, there is limited evidence of 
the use of point-of-care (non-laboratory) tests in mainstream sexual 
health services for chlamydia. A published service evaluation of the 
use of the Cepheid GeneXpert undertaken in a UK sexual health 
clinic found that due to the 90 minute processing time only 14.3% 
of males and 28.6% of females waited to receive their results [41]. 
Further developments in chlamydia point-of-care tests include low 
cost handheld devices [42], and the exploration of ‘accelerated partner 
therapy’ for improving partner notification and treatment uptake 
[43,44]. In contrast, in April 2014 regulations were relaxed to allow 
the sale of CE marked self-test HIV kits in England [15]. Although 
these kits indicate that a person may have HIV, a confirmatory 
laboratory test is still required in the UK, and also in the United States 
[45]. To date, none of the technological advances in the UK support 
Table 1:  Terminology Telemedicine, eHealth and mHealth: Summary of key 
features and generic examples of their use.
Telemedicine eHealth mHealth
Key 
Features
Linked directly 
to clinical 
service 
delivery
Broad scope including 
other non-clinical IT 
solutions within health
Subset of eHealth 
involving use of mobile 
devices such as phones 
or tablets
Examples
Virtual clinics;
Remote 
monitoring.
Electronic health records 
(EHR);
ePrescribing;
eCommerce within health;
Health information;
Delivery of web-based 
services/ interventions.
SMS Appointment 
Reminders;
Apps (health 
information, public 
health interventions, 
monitoring);
Remote monitoring;
Diagnostics.
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the provision of a fully remote NHS service, including treatment. Less 
ambitious provision of partially remote STI services, including online 
pathways for results notification, treatment provision and partner 
notification, does now exist. The main model of online NHS service 
provision for STIs involves online ordering of postal home sampling 
test kits with, for those who test positive, either signposting to the 
clinic for treatment or a telephone consultation followed by a GP 
prescription or postal treatment. 
For chlamydia (and in some cases gonorrhoea) testing services, 
such as freetest.me and checkurself.org.uk, enable online ordering 
of a test kit for self-sampling for the 16-24-year-old population and 
provide a freepost envelope for the sample to be sent to the laboratory 
for analysis. Freetest.me also provides an online results notification 
service. However, data published by Public Health England indicate 
that only 5% of chlamydia tests undertaken as part of the National 
Chlamydia Screening Programme were ordered online [46]. 
Extension of online ordering to include a wider range of STI test kits 
for self-sampling is now underway e.g. HIV, gonorrhoea, Hepatitis B 
and C, and syphilis [47]. Results notification by text message has been 
adopted in many NHS clinics since the mid-2000s in response to the 
drive to achieve a 48-hour access target [48].
Looking at sexual health services beyond the UK, there are 
limited examples of reported studies involving telemedicine, eHealth 
and/ or mHealth in high income countries. A pilot of telemedicine for 
sexual health for young people in rural Australia reported that most 
preferred the telemedicine service to attending a clinic [49], and a pilot 
of an online chlamydia testing and treatment service in California 
was found to deliver high patient satisfaction at a potentially lower 
cost [50].
Whilst some examples exist of the adoption of eHealth and 
mHealth across England, similarly to the WHO survey, to date the 
evidence of adoption is sporadic, with variations in availability of 
options dependent on geographical area. 
Discussion
Although NHS services do not currently incorporate an online 
treatment (antibiotic prescription) stage, the findings of a feasibility 
study of an online NHS chlamydia treatment and management 
system have recently been reported demonstrating a safe and feasible 
alternative with similar outcomes to traditional services [51]. This 
eHealth service differs from existing interventions aimed at reducing 
prevalence and transmission of chlamydia in that more elements 
of the service were delivered electronically. The service provided 
a web link to results, an online consultation, links to online health 
promotion, online partner notification, and an e-prescription for 
treatment. Patients judged to be unsuitable for online care (for 
example, those with symptoms) were automatically signposted to 
telephone support and clinic care. Internet and mobile phone delivery 
could be particularly appropriate for sexual health interventions, for 
which sensitivity, non-judgmental support, and privacy are required 
[7]. These developments show promise for improving the clinical 
and/ or cost-effectiveness of current chlamydia screening pathways.
Early trials of eSexual health promotion interventions also 
indicate possible benefits in terms of increased safe sex behaviours, 
as well as increased testing for sexually transmitted infections and 
service use, although some of these trials could have been prone to 
bias [52]. However, the views of young people about new clinical 
pathways incorporating telemedicine and telehealth will be important 
for their successful introduction. These are currently being explored 
in the UK [53]. Finally, internet and mobile phone service delivery 
pathways could be particularly effective for promoting safe sex 
behaviours while individuals are waiting for test results and this is 
currently also being explored [54]. 
Interventions based on information and communication 
technologies (i.e. eHealth) have the potential to increase access to 
care, change behavioural risk factors, and increase self-management 
of disease with low costs with interventions for smoking-cessation 
support and diabetes management cost-effective and feasible on a 
national scale[55,56].
To date, there has been little published in respect of methods 
for evaluation of the effectiveness and cost-effectiveness of eHealth 
and mHealth technologies. Existing health technology assessment 
methods, which were primarily developed for the evaluation of 
discrete interventions such as drugs and devices [57], are not optimal 
for eHealth and mHealth interventions owing to the pace of base 
technology development (e.g. smartphones, smartphone consumables 
and apps/ software), the lack of experience with adoption, and the lack 
of tools to measure outcomes. This has recently been acknowledged 
as one of the main limiting factors for amassing an evidence base for 
eHealth interventions [56].
The pace of technology development means that there are 
constantly new products being developed, with the potential for new 
technology to improve chlamydia screening services, particularly 
given the high proportion of the population aged 15 to 24 years with 
access to the base technology e.g. the internet and a smartphone. There 
is also an opportunity for manufacturers and health services to learn 
across these developments to further enhance the delivery of care. 
However, there is also a risk that development of new technologies 
in isolation will lead to fragmented solutions to individual aspects 
of the service pathway and that traditional evaluation methods will 
mean that the technology is obsolete before the research findings 
are published. In addition to awareness of these developments, 
collaboration will be needed to ensure the development of more 
effective products and to refine evaluation methods to develop the 
knowledge base to inform decisions on the adoption of eHealth and 
mHealth technologies by the NHS.
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